Reaktionsgleichung
[CH3:1][N:2]([CH3:15])[C:3]1[C:12]2[C:7](=[CH:8][CH:9]=[C:10]([CH:13]=O)[CH:11]=2)[N:6]=[CH:5][N:4]=1.[NH:16]=[C:17]1[NH:21][C:20](=[O:22])[CH2:19][S:18]1>>[NH:16]=[C:17]1[NH:21][C:20](=[O:22])[C:19](=[CH:13][C:10]2[CH:11]=[C:12]3[C:7](=[CH:8][CH:9]=2)[N:6]=[CH:5][N:4]=[C:3]3[N:2]([CH3:15])[CH3:1])[S:18]1Komponenten
3
Versuchsvorschrift
Following the general method as outlined in Example 1, starting from 4-piperidine-quinazoline-6-carbaldehyde (intermediate 14) and 2-imino-1,3-thiazolidin-4-one, the title compound was obtained.
Quellen und Nachweise
- ORD-Eintrag
- ord-7796b2709bf24bc1a3c00daa103a756d
- Quelldatensatz
- uspto-grants-2010_12
- Patentnummer
- US07846925B2
Verknüpfte Notizen
Wird geladen…